KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 89 filers reported holding KEROS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,505,337 | +305.8% | 204,057 | +411.5% | 0.00% | +200.0% |
| Q2 2023 | $1,603,021 | +153888.6% | 39,896 | +63.7% | 0.00% | 0.0% |
| Q1 2023 | $1,041 | -88.0% | 24,373 | -86.6% | 0.00% | -80.0% |
| Q4 2022 | $8,705 | -99.8% | 181,277 | +176.0% | 0.01% | +150.0% |
| Q1 2022 | $3,572,000 | +15.7% | 65,688 | +24.5% | 0.00% | 0.0% |
| Q4 2021 | $3,086,000 | -57.1% | 52,744 | -71.0% | 0.00% | -50.0% |
| Q3 2021 | $7,195,000 | +44.9% | 181,876 | +55.6% | 0.00% | +33.3% |
| Q2 2021 | $4,965,000 | -38.1% | 116,915 | -10.2% | 0.00% | -50.0% |
| Q1 2021 | $8,018,000 | +29.2% | 130,265 | +48.1% | 0.01% | +50.0% |
| Q4 2020 | $6,204,000 | +1740.9% | 87,956 | +906.5% | 0.00% | – |
| Q3 2020 | $337,000 | – | 8,739 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 407,633 | $12,995,340 | 5.15% |
| Opaleye Management Inc. | 360,400 | $11,489,552 | 3.74% |
| Parkman Healthcare Partners LLC | 298,475 | $9,515,383 | 1.74% |
| BRAIDWELL LP | 1,357,309 | $43,271,011 | 1.37% |
| First Light Asset Management, LLC | 421,438 | $13,435,443 | 1.28% |
| Orbimed Advisors | 1,514,734 | $48,289,720 | 1.03% |
| Yiheng Capital Management, L.P. | 554,151 | $17,666,334 | 0.90% |
| Nantahala Capital Management | 328,781 | $10,481,538 | 0.90% |
| DAFNA Capital Management LLC | 65,961 | $2,102,837 | 0.65% |
| EDBI Pte Ltd | 10,105 | $322,147 | 0.35% |